Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Psychiatric Services (Washington, D.C.)|October 1, 2020
The Eleventh Judicial Circuit Criminal Mental Health Project: Improving Access to Mental Health Treatment in Miami-Dade CountySarah D Mills, Tim Coffey, John W Newcomer, et al.
The American Journal of Psychiatry|January 17, 2009
Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agentsDan W Haupt, Lisa C Rosenblatt, Edward Kim, et al.
Psychiatric Services (Washington, D.C.)|March 2, 2017
Nonpsychiatric Outpatient Care for Adults With Serious Mental Illness in California: Who Is Being Left Behind?Maria E Garcia, Dean Schillinger, Eric Vittinghoff, et al.
Psychiatry Research|December 2, 2004
Effects of dexamethasone on declarative memory function in posttraumatic stress disorderJ Douglas Bremner, Meena Vythilingam, Eric Vermetten, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 27, 2016
Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trialEric J Lenze, Nuri B Farber, Evan Kharasch, et al.
Journal of Clinical Psychopharmacology|July 26, 2019
Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 ProgramAnne Andorn, Jay Graham, John Csernansky, et al.
Journal of General Internal Medicine|November 2, 2017
Diabetes Screening among Antipsychotic-Treated Adults with Severe Mental Illness in an Integrated Delivery System: A Retrospective Cohort StudyChristina Mangurian, Dean Schillinger, John W Newcomer, et al.
Psychiatric Services (Washington, D.C.)|September 2, 2015
The Role of Clinical Setting and Management Approach in Metabolic Testing Among Youths and Adults Treated With AntipsychoticsGinger E Nicol, Elizabeth J Campagna, Lauren D Garfield, et al.
International Journal of Geriatric Psychiatry|December 17, 2011
Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot studyEric J Lenze, Elizabeth R Skidmore, Amy E Begley, et al.
Pageof 10